Long-acting Hormone Injection Report

By www.reliablemarketforecast.com

Report Details

Report Name

Global Long-acting Hormone Injection Market Growth 2024-2030 Story

Pages

112

Price

$ 3660

Features

Long-acting Hormone Injection Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              "Pfizer"|||"Bayer"|||"Organon"|||"Merck & Co. Inc."|||"Adare Pharma Solutions"|||"Mylan NV"|||"Novo Nordisk"|||"Genentech"|||"Eli Lily"|||"Shree Venkatesh International Limited"|||"LG Chem"|||"Anhui Anke Biotechnology"|||"Zhongshan Sinobioway Hygene Biomedicine"|||"Shanghai United Cell Biotechnology"|||"Changchun GeneScience Pharmaceutical"            

Countries Covered

              "United States"|||"China"|||"Canada"|||"Mexico"|||"Brazil"|||"Japan"|||"Korea"|||"Southeast Asia"|||"India"|||"Australia"|||"Germany"|||"France"|||"UK"|||"Italy"|||"Russia"|||"Egypt"|||"South Africa"|||"Israel"|||"Turkey"|||"GCC Countries"            

Regions Covered

              global            

Prices

Single User License:

$ 3660

Multi User License:

$ 5490

Enterprise/Corporate User License:

$ 7320